KIMBERLY SALYER: Open Payments
NPI 1811761893 · WEST COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 19 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $179 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 9 | $145 |
| Astellas Pharma US Inc | 3 | $61 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $30 |
| Novo Nordisk Inc | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: ZURZUVAE, Veozah, MYFEMBREE, Wegovy, INJECTAFER, VRAYLAR, Qelbree, LILETTA.
Industry payments across SC — which companies pay providers there.
